Contrave

Orexigen: Contrave FDA Panel Preview
TheStreet.com
Tue, 11/30/10 - 08:02 am
FDA
advisory panels
Orexigen
Contrave
obesity
Arena Pharmaceuticals
Vivus
Long Odds Seen For Diet Drugs
WSJ Online
Tue, 10/26/10 - 12:37 pm
obesity
Arena Pharmaceuticals
Eisai
Orexigen
Contrave
FDA's Top Q4 Blockbuster Drug Decisions
Fierce Biotech
Tue, 10/12/10 - 11:26 am
Linjeta
Biodel
Afrezza
MannKind
FDA
Benlysta
Human Genome
GSK
Bydureon
Eli Lilly
Amylin
Alkermes
Brilinta
AstraZeneca
Pradaxa
Boehringer Ingelheim
Qnexa
Vivus
Contrave
Orexigen
ipilimumab
Bristol-Myers Squibb
Merck KGaA
cladribine
Vivus Races to Capture U.S. Approval of Obesity Drug
Seeking Alpha
Mon, 09/27/10 - 10:43 am
obesity
Vivus
Qnexa
Orexigen
Contrave
Arena Pharmaceuticals
Biotech Investor Calendar: Obesity Drugs
TheStreet.com
Tue, 09/21/10 - 12:10 pm
Vivus
Qnexa
Orexigen
obesity
Contrave
Arena Pharmaceuticals
Arena Pharma: FDA Panel Live Blog
TheStreet.com
Thu, 09/16/10 - 12:18 pm
FDA
advisory panels
Arena Pharmaceuticals
obesity
Orexigen
Abbott Laboratories
Contrave
Meridia
Speculative Bubble Growing Around Diet Drugs
BNET Pharma
Tue, 09/14/10 - 05:42 pm
Arena Pharmaceuticals
obesity
Takeda
Orexigen
Contrave
Abbott Laboratories
Meridia
Qnexa
Vivus
Arena Pharma Will Fail: Hedge Fund Poll
TheStreet.com
Fri, 09/10/10 - 09:32 am
Arena Pharmaceuticals
obesity
Vivus
Qnexa
Contrave
Orexigen
Arena Pharma: Understanding the Market for Anti-Obesity Drugs
Seeking Alpha
Fri, 09/3/10 - 11:57 am
Arena Pharmaceuticals
Contrave
Orexigen
Vivus
obesity
Qnexa
Volume Hunter: Diet Stocks Lift Biotech
Yahoo/IndieResearch
Thu, 09/2/10 - 04:01 pm
diet drugs
biotech
Arena Pharmaceuticals
Dendreon
Provenge
Exelixis
Vivus
Orexigen
Takeda
Contrave
Martek
Orexigen, Takeda Tie Knot on Obesity Drug
TheStreet.com
Thu, 09/2/10 - 08:18 am
Orexigen
Takeda
obesity
Contrave
partnerships
Arena Pharma: Using Options to Trade on FDA's Decision for Key Obesity Drug
Seeking Alpha
Fri, 08/27/10 - 11:10 am
Arena Pharmaceuticals
obesity
FDA
Vivus
Orexigen
Contrave
Qnexa
Arena's Obesity Drug Likely to Pass FDA Panel With Flying Colors
Seeking Alpha
Mon, 08/9/10 - 09:46 am
Arena Pharmaceuticals
obesity
Vivus
Orexigen
Contrave
Qnexa
FDA
Vivus slides after analyst downgrades to 'Sell'
Yahoo/AP
Tue, 08/3/10 - 07:01 pm
Vivus
downgrades
obesity
Qnexa
Orexigen
Contrave
Arena Pharmaceuticals
Orexigen Steps Up Pace in Obesity Drug Race
Seeking Alpha
Sun, 08/1/10 - 02:47 pm
Orexigen
Arena Pharmaceuticals
Vivus
Contrave
Qnexa
Orexigen's Two-Drug Obesity Pill Cuts Hunger, Cravings, Weight in Study
Bloomberg
Fri, 07/30/10 - 11:05 am
Orexigen
obesity
Contrave
Vivus
Arena Pharmaceuticals
Vivus's Obesity Drug Raises Familiar Questions
Seeking Alpha
Mon, 07/26/10 - 11:16 am
Vivus
obesity
Arena Pharmaceuticals
Contrave
Orexigen
Qnexa
Safety Concerns May Sink Both Vivus and Its Obesity Drug Qnexa
BNET Pharma
Wed, 07/21/10 - 03:55 pm
obesity
Vivus
Qnexa
FDA
Arena Pharmaceuticals
Contrave
Orexigen
Lessons Learned About the Outlook for New Obesity Drug Approval
Motley Fool
Sun, 07/18/10 - 07:43 am
obesity
Arena Pharmaceuticals
Vivus
Qnexa
Contrave
Orexigen
Vivus tanks, Arena rallies on FDA diet-drug vote
Marketwatch
Fri, 07/16/10 - 10:05 am
Vivus
Arena Pharmaceuticals
FDA
Orexigen
Contrave
Qnexa

Pages